These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
676 related items for PubMed ID: 8099202
1. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L. Nature; 1993 Jun 03; 363(6428):458-60. PubMed ID: 8099202 [Abstract] [Full Text] [Related]
2. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gardner E, Scheumann GF, Jackson CE, Tunnacliffe A. Hum Mol Genet; 1994 Feb 03; 3(2):237-41. PubMed ID: 7911697 [Abstract] [Full Text] [Related]
3. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells SA. Hum Mol Genet; 1993 Jul 03; 2(7):851-6. PubMed ID: 8103403 [Abstract] [Full Text] [Related]
4. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Hofstra RM, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Höppener JW, van Amstel HK, Romeo G. Nature; 1994 Jan 27; 367(6461):375-6. PubMed ID: 7906866 [Abstract] [Full Text] [Related]
6. Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A (Sipple's syndrome). Oishi S, Sato T, Takiguchi-Shirahama S, Nakamura Y. Endocr J; 1995 Aug 27; 42(4):527-36. PubMed ID: 8556060 [Abstract] [Full Text] [Related]
7. Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests. Xue F, Yu H, Maurer LH, Memoli VA, Nutile-McMenemy N, Schuster MK, Bowden DW, Mao J, Noll WW. Hum Mol Genet; 1994 Apr 27; 3(4):635-8. PubMed ID: 7915165 [Abstract] [Full Text] [Related]
8. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers]. Sansó G, Domené HM, Iorcansky S, Barontini M. Medicina (B Aires); 1998 Apr 27; 58(2):179-84. PubMed ID: 9706252 [Abstract] [Full Text] [Related]
11. Absence of mutations in the MEN2A region of the ret proto-oncogene in non-MEN 2A phaeochromocytomas. Chew SL, Lavender P, Jain A, Weber A, Ross RJ, Wass JA, Besser GM, Clark AJ. Clin Endocrinol (Oxf); 1995 Jan 27; 42(1):17-21. PubMed ID: 7889627 [Abstract] [Full Text] [Related]
15. Germline mutations of the RET proto-oncogene in eight Japanese patients with multiple endocrine neoplasia type 2A (MEN2A). Takiguchi-Shirahama S, Koyama K, Miyauchi A, Wakasugi T, Oishi S, Takami H, Hikiji K, Nakamura Y. Hum Genet; 1995 Feb 27; 95(2):187-90. PubMed ID: 7860065 [Abstract] [Full Text] [Related]